from 31/12/14 report
"Expansion of the product pipeline is critical to provide income diversification and remains a key priority for the business. Progress to date has been encouraging, with a wide variety of projects explored to further exploit our existing intellectual property. A number of development initiatives have been reviewed for market feasibility and initial Iaboratory research completed. The Directors regularly review projects and
will update the market when progress is made". Does this sound familiar???
also from that report "The two Hexima projects remain on hold, pending resolution of our dispute".
Has it been resolved and if so what are the terms of it as I understood that an officeholder in Acrux is also the main officeholder in Helix!!! - happy to be corrected.
- Forums
- ASX - By Stock
- ACR
- Ann: Acrux Appendix 4D - December 2015
Ann: Acrux Appendix 4D - December 2015, page-12
Featured News
Add ACR (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.4¢ |
Change
-0.001(2.22%) |
Mkt cap ! $12.79M |
Open | High | Low | Value | Volume |
4.5¢ | 4.5¢ | 4.4¢ | $10.91K | 243.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 82022 | 4.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.6¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 82022 | 0.044 |
2 | 547000 | 0.043 |
2 | 94414 | 0.041 |
5 | 442500 | 0.040 |
1 | 78000 | 0.038 |
Price($) | Vol. | No. |
---|---|---|
0.046 | 10000 | 1 |
0.048 | 44500 | 3 |
0.049 | 120000 | 1 |
0.052 | 103000 | 2 |
0.055 | 120542 | 1 |
Last trade - 15.11pm 15/11/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online